CD4 and tuberculosis: In this high-risk region, the use of isoniazid preventive therapy (IPT), co-trimoxazole prophylaxis, and antiretroviral therapy should be scaled up continuously to reduce opportunistic infections like tuberculosis and increase CD4 counts.